Boston Scientific Logo
Back to main page Print Complete
ICD Product Longevity
U.S. Reason for Out of Service

CRM Product Performance Report Q4 2011

TELIGEN VR

Models E102/E103/F102/F103



U.S. Summary
U.S. Registered Implants: 33,000
U.S. Approval Date: May 2008
U.S. Estimated Active Implants: 29,000
U.S. Normal Battery Depletions: 18
U.S. Unconfirmed Reports of
Premature Battery Depletion
: 0
U.S. Malfunctions:46
Without Compromised Therapy:15
With Compromised Therapy:31
Battery Depletions and Malfunctions


Malfunctions Only
U.S. Survival Probability
 Year 1 2 34 56 78 910
Non Advisory Population

Registered Implants: 17000
Depletions and Malfunctions(%)
(Confidence Interval)
99.88
(-0.1/+0.1)
99.85
@ 20 mo.

(-0.1/+0.1)
 Malfunctions Only(%)
(Confidence Interval)
99.91
(-0.1/+0.0)
99.91
@ 20 mo.

(-0.1/+0.0)
  Effective Sample Size 5706466

Subpectoral Implant 2009*

Registered Implants: 24000
Depletions and Malfunctions(%)
(Confidence Interval)
99.77
(-0.1/+0.1)
99.56
(-0.1/+0.1)
99.57
(-0.1/+0.1)
99.57
@ 38

(-0.1/+0.1)
 Malfunctions Only(%)
(Confidence Interval)
99.80
(-0.1/+0.1)
99.74
(-0.1/+0.1)
99.72
(-0.1/+0.1)
99.72
@ 38

(-0.1/+0.1)
  Effective Sample Size 1368894761191NaN

*Devices subject to an advisory. Refer to the Advisories for more details.